(Cambridge), software for inbound marketing and website personalization. Seeking in IPO
: $100 million. Read more: HubSpot files for $100 million IPO
(Pictured at center is chief executive Brian Halligan)
(Boston), therapeutics for the treatment of gastrointestinal diseases. Seeking in IPO
: $86 million. Read more: Rhythm Pharma files plans for IPO
(Waltham), a treatment for patients with therapy-resistant cancers. Company had previously filed its plans for going public, then postponed the IPO in June, but has now refiled its plans with new terms. Seeking in IPO
: $74 million. Read more: IPO window shuts for two Massachusetts biotech companies
We’re two-thirds of the way into 2014, and Massachusetts has already blown past last year in terms of IPOs by innovation-related companies. And more could be on the way soon.
Click through the gallery above to see the seven local tech and biotech firms looking to go public in coming months. The IPOs are ordered by dollar amount being sought.
For a look at the Boston-area, innovation-economy companies that have already pulled off IPOs in 2014, there’s now an infographic for that. The total for the year so far is 17 IPOs in tech and biotech from Massachusetts, versus 10 in 2013.
Editor’s note: This post has been modified since it was first posted, to add Tokai Pharmaceuticals. Images of IPO and coins and of Massachusetts map via Shutterstock.